Skip to main content

Table 2 Follow-up measures of medical consumption. Data are weighted for the sampling scheme.

From: Follow-up study on health care use of patients with somatoform, anxiety and depressive disorders in primary care

  None of the psychiatric disorder disorders Anxiety or depressive disorder Somatoform disorders, undifferentiated * Somatoform disorder, others * Total
Medical consumption (n = 274) (n = 51) (n = 94) (n = 12) (n = 400)
Data from patient records (1 yr):      
Face-to-face contact with FP#:      
   mean (se) median 4.8 (0.2) 4 7.5 (0.9) 7 6.9 (0.6) 5 9.8 (3.5) 5.5 5.5 (0.3) 4
Somatic prescriptions by FP&:      
   mean (se) median 8.0 (0.6) 5 13.0 (3.6) 6 12.4 (1.7) 8 14.3 (4.2) 8.5 9.7 (0.7) 5
   % use 86% 82% 95% 92% 87%
Antidepressants by FP&:      
   mean (se) median 0.4 (0.1) 0 3.5 (1.0) 0 2.1 (0.4) 0 4.7 (2.1) 1 1.0 (0.2) 0
   % use 7% 40% 32% 58% 16%
Psycholeptics by FP&:      
   mean (se) median 0.6 (0.1) 0 4.2 (2.5) 0 2.3 (0.6) 0 4.9 (3.2) 0 1.5 (0.4) 0
   % use 20% 37% 46% 25% 27%
Data from questionnaire (1/2 yr):      
- contact with psychiatrist, psychologist or social worker 14% 59% 39% 68% 23%
- visit to hospital or specialist 48% 43% 48% 33% 48%
- admission to hospital 7% 14% 10% 0% 8%
  1. * Undifferentiated somatoform disorders included chronic pain disorders. Other somatoform disorders: hypochondriasis, somatization disorder and conversion disorder. # Consultations and visits within office hours &FP prescriptions include repeats by FP of medication that was initiated by specialists